MATINAS BIOPHARMA HOLDINGS, INC. Business Combination, Contingent Consideration, Liability, Noncurrent
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Business Combination, Contingent Consideration, Liability, Noncurrent of $781.73 thousand as of 2015-09-30, per its 10-Q filed 2015-11-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent · last filed 2015-11-10
- 2015-09-30: Business Combination, Contingent Consideration, Liability, Noncurrent $781.73K.
- 2014-12-31: Business Combination, Contingent Consideration, Liability, Noncurrent $0.00.
| Period end | Business Combination, Contingent Consideration, Liability, Noncurrent |
|---|---|
| 2015-09-30 | $781.73K 10-Q · filed 2015-11-10 |
| 2014-12-31 | $0.00 10-Q · filed 2015-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |